Mesenchymal stem cells impair in vivo T-cell priming by dendritic cells.
about
Mesenchymal Stem Cells and Myeloid Derived Suppressor Cells: Common Traits in Immune RegulationAdvances in the Use of Stem Cells in Veterinary Medicine: From Basic Research to Clinical PracticeMesenchymal Stem and Progenitor Cells in Normal and Dysplastic Hematopoiesis-Masters of Survival and Clonality?Mesenchymal stromal cell therapy in liver disease: opportunities and lessons to be learnt?Safety and Efficacy Endpoints for Mesenchymal Stromal Cell Therapy in Renal Transplant RecipientsThe effects of TLR activation on T-cell development and differentiationRecent progress toward understanding the physiological function of bone marrow mesenchymal stem cellsMouse mesenchymal stem cells inhibit high endothelial cell activation and lymphocyte homing to lymph nodes by releasing TIMP-1.Intravital imaging of mesenchymal stem cell trafficking and association with platelets and neutrophils.Biodistribution, migration and homing of systemically applied mesenchymal stem/stromal cellsHuman mesenchymal stem cells (MSCs) for treatment towards immune- and inflammation-mediated diseases: review of current clinical trialsMesenchymal Stem Cells Regulate the Innate and Adaptive Immune Responses Dampening Arthritis ProgressionWharton's Jelly-Derived Mesenchymal Stromal Cells as a Promising Cellular Therapeutic Strategy for the Management of Graft-versus-Host DiseaseImmunogenicity of allogeneic mesenchymal stromal cells: what has been seen in vitro and in vivo?Mesenchymal stem cell and regenerative medicine: regeneration versus immunomodulatory challengesMesenchymal stromal cell therapy is associated with increased adenovirus-associated but not cytomegalovirus-associated mortality in children with severe acute graft-versus-host disease.Preclinical efficacy and mechanisms of mesenchymal stem cells in animal models of autoimmune diseases.Human mesenchymal stromal cells from adult and neonatal sources: a comparative in vitro analysis of their immunosuppressive properties against T cells.MSC-derived Extracellular Vesicles Attenuate Immune Responses in Two Autoimmune Murine Models: Type 1 Diabetes and Uveoretinitis.Functional effects of TGF-β1 on mesenchymal stem cell mobilization in cockroach allergen-induced asthmaCD39-mediated effect of human bone marrow-derived mesenchymal stem cells on the human Th17 cell functionHow stem cells speak with host immune cells in inflammatory brain diseasesMesenchymal stem cells and their therapeutic applications in inflammatory bowel disease.Mesenchymal stem cells: Emerging mechanisms of immunomodulation and therapy.Endometrial regenerative cells as a novel cell therapy attenuate experimental colitis in mice.Anaerobic co-culture of mesenchymal stem cells and anaerobic pathogens - a new in vitro model systemImmune suppressive effects of tonsil-derived mesenchymal stem cells on mouse bone-marrow-derived dendritic cells."Second-generation" stem cells for cardiac repairNG2, a common denominator for neuroinflammation, blood-brain barrier alteration, and oligodendrocyte precursor response in EAE, plays a role in dendritic cell activationThe potential of mesenchymal stromal cells as a novel cellular therapy for multiple sclerosis.Immunomodulatory effect of mesenchymal stem cells on B cells.How mesenchymal stem cells interact with tissue immune responses.Placenta-derived mesenchymal stem cells possess better immunoregulatory properties compared to their cord-derived counterparts-a paired sample study.The role of recipient T cells in mesenchymal stem cell-based tissue regenerationPorcine lung mesenchymal stromal cells possess differentiation and immunoregulatory properties.Aryl Hydrocarbon Receptor Protects Lungs from Cockroach Allergen-Induced Inflammation by Modulating Mesenchymal Stem Cells.Ectonucleotidases in solid organ and allogeneic hematopoietic cell transplantationHuman oral mucosa and gingiva: a unique reservoir for mesenchymal stem cells.Mesenchymal stem cell-based therapy.Comparison of allogeneic vs autologous bone marrow–derived mesenchymal stem cells delivered by transendocardial injection in patients with ischemic cardiomyopathy: the POSEIDON randomized trial
P2860
Q26741252-2520F23E-E675-40CE-874A-6A8068C7EFF3Q26744494-A9FD3ADA-FB79-408A-8BFB-595E1CC31629Q26746104-161B4ED2-9183-4233-9E91-FD71B8D517FBQ26796475-16C25CEE-D637-46AB-A34E-2C364ECED2C9Q26799916-AA1975BB-25FF-4252-B85A-230617B2F4D2Q27001581-B07C73F6-246D-429F-B042-86B4D7BAE8D9Q27007493-32E07BEB-44E2-4085-A53E-6E17DF587327Q27320221-4CE21FE9-86FE-4E48-8AC2-86DECBCF8655Q27329981-072A06A8-DC38-46A8-8A3C-502F9B09E6EFQ28069791-D5FBDDFE-27CC-4DED-A51D-CBFDF46A0BA0Q28071916-11514533-B7D4-43F1-A8FC-7E34ABC2F9B9Q28078360-94EA041C-A0FC-44F0-BA72-708EE1390B26Q28083027-D0C39DB3-7D61-4259-9026-16C1E4CD0247Q28084829-1F1E4BDA-57A4-475E-9717-32E4C7A1DCB2Q30009860-ED107D44-E83C-4659-B58D-D2E2DD6DE954Q30585387-AFCFB760-253F-46D6-990F-B41C64CCC56CQ33619017-8BB8022A-3C6D-4E40-9A2A-31B787E6F240Q33637705-2104BBF3-6F54-4B52-9475-D3D76D408C9CQ33659353-908796B4-7333-4E33-82BD-3405A7559963Q33690696-7FC73F92-D058-493F-92C9-9EB8771FEAD2Q33692614-21901F74-D017-4A4A-BDCB-B300CE76794AQ33776557-98E47C90-2CE8-4993-AF67-5D3F6E8902A6Q33914228-31269627-195A-4649-9701-DE14FD0FBE73Q34259085-4FED459B-2A7D-4C09-B5A2-70B6679796B1Q34728538-B9999108-6312-47D0-83C1-0008D4918CD0Q35040840-F62E5C4E-F81E-4065-AF59-612D42BFE5D9Q35133847-CF4046DC-B2B8-40BA-90B3-A7C1257EB1A6Q35205665-EE389781-E480-4C54-ACDA-12810DA7BC28Q35973447-9A25BF01-6E11-4EEE-AD0F-95E18BB1F90FQ36054671-32D9243B-3468-4076-954E-AACA26F52F1AQ36105639-E6530DDA-60B7-405E-9373-591B87EA5E70Q36141205-71C561B6-D8B0-4B95-8E54-6EA4697DB8EAQ36216394-2B312929-6893-40B1-9891-F60767EE39C5Q36268038-BB6A9081-F458-48D1-B5D0-39E4873DCE31Q36274184-55458676-52FC-4C26-96FA-E88D89B9A658Q36349594-57D927F1-0EFB-41F9-99A5-DFB2FA345CBEQ36350059-C9180B18-BA2C-4C1E-9F83-122E582F5DBDQ36375068-F1F90C30-2559-4FC5-A9FB-850F822329B2Q36546424-82641A19-C71A-4DCD-B858-9594C79E4BA7Q36603453-329470CD-B05F-41C6-91AC-42AFA1E5C8C3
P2860
Mesenchymal stem cells impair in vivo T-cell priming by dendritic cells.
description
2011 nî lūn-bûn
@nan
2011 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Mesenchymal stem cells impair in vivo T-cell priming by dendritic cells.
@ast
Mesenchymal stem cells impair in vivo T-cell priming by dendritic cells.
@en
type
label
Mesenchymal stem cells impair in vivo T-cell priming by dendritic cells.
@ast
Mesenchymal stem cells impair in vivo T-cell priming by dendritic cells.
@en
prefLabel
Mesenchymal stem cells impair in vivo T-cell priming by dendritic cells.
@ast
Mesenchymal stem cells impair in vivo T-cell priming by dendritic cells.
@en
P2093
P2860
P50
P356
P1476
Mesenchymal stem cells impair in vivo T-cell priming by dendritic cells.
@en
P2093
Arinna Bertoni
Elisabetta Traggiai
Michela Massollo
Sabrina Chiesa
Sara Morando
Silvia Morbelli
Soraya Tabera Bartolomé
P2860
P304
17384-17389
P356
10.1073/PNAS.1103650108
P407
P577
2011-09-29T00:00:00Z